To visualize the norepinephrine transporters (NETs) in various brain diseases, we developed radioiodinated (2S,aS)-2-(a-(2-iodophenoxy)benzyl)morpholine ((S,S)-IPBM). This radioligand achieved the basic requirements for NET imaging. In this study, we assessed the potential of radioiodinated (S,S)-IPBM as an imaging biomarker of NET to obtain diagnostic information about depression in relation to NET expression in the brain using a rat depression model. The ex vivo autoradiographic experiments using the (S,S)- NET, located on presynaptic terminals of the noradrenergic nervous system, terminates the action of norepinephrine via reuptake into the presynaptic neurons.
I]IPBM showed significantly lower accumulation of radioactivity in the locus coeruleus (LC) and the anteroventricular thalamic nucleus (AVTN) of the depression group than in those of the control group. Consequently, in vitro autoradiographic experiments showed that NET maximum binding (B max ) values in the LC and AVTN, known as NET-rich regions, were significantly decreased in the rat model of depression when compared to those of the control rats. In addition, there was an extremely good correlation between NET 
A RADIOIODINATED REBOXETINE ANALOGUE, (2S,aS)-2-(a-(2-iodophenoxy)benzyl)morpholine ((S,S)-IPBM)
, has been developed as an imaging agent of cerebral norepinephrine transporter (NET) expression. 1 (S,S)-IPBM shows high affinity and selectivity to NET in vitro and in vivo, and the regional accumulation of radioiodinated (S,S)-IPBM in the brain correlates well with NET expression in the brain.
NET, located on presynaptic terminals of the noradrenergic nervous system, terminates the action of norepinephrine via reuptake into the presynaptic neurons.
NET not only regulates neurotransmission in the noradrenergic nervous system but also plays a very important role in presynaptic and postsynaptic homeostasis.
2-4 NET has been implicated in the pathophysiology of numerous neuropsychiatric and mood disorders, including major depression, 5 arousal, anxiety, and attention-deficit/hyperactivity disorders. [6] [7] [8] About 16% of the population is estimated to be affected by major depression one or more times during their lifetime. 9 Therefore, the association between major depression and NET has been under intense investigation from the point of view of elucidating the etiologic mechanism of major depression and the prediction of therapeutic effects of antidepressants. However, the relationship between major depression and NET remains unclear. For example, NET gene variation has been investigated in major depression, but with contradictory results. [10] [11] [12] With regard to protein expression of NET in depression patients, only Klimek and colleagues showed reduced expression of NET in the locus coeruleus (LC) compared to age-matched normal control subjects using brain tissue collected postmortem from patients diagnosed with major depression. 5 Therefore, it is important to image the function of NET in depression patients to understand the etiology of depression and the mechanisms of antidepressants.
In this study, we investigated the potential of radioiodinated (S,S)-IPBM as an imaging agent of NET for the diagnosis of depression. As a depression model, a reserpine-treatmented rat model 13 was selected, and an ex vivo autoradiographic study using radioiodinated (S,S)-IPBM was performed for comparison of regional NET expression. 125 I]IPBM was prepared according to the previously reported method. 1 All chemicals used in this study were of reagent grade.
Materials and Methods

General
Animals
Animal studies were conducted in accordance with our institutional guidelines, and the experimental procedures were approved by the Kyoto University Animal Care Committee. Male rats of the Wistar strain weighing 200 to 220 g were used. On arrival at the facility, the rats were housed four to a cage at a constant temperature of 25uC under a 12-hour light/dark cycle, with food and water available ad libitum for at least 1 week prior to the experiment.
Reserpine was injected daily for 14 days at a dose of 0.1 mg/kg subcutaneously. 13 To minimize the influence of circadian rhythms, the experiments were performed between 13:00 and 15:00 hours. 14 
Ex Vivo Autoradiographic Experiments
Sixty minutes after the last injection of reserpine, the rats were intravenously injected with 2.22 MBq of (S,S)-[ 125 I]IPBM (control group: n 5 4; reserpine-treated group: n 5 4). At 180 minutes after the injection, the rats were decapitated under light ether anesthesia, and their brains were rapidly removed, frozen, and cut into sections 20 mm thick with a cryostat microtome. The sections were thawmounted on precleaned silane-coated slides. 125 I]IPBM autoradiograms. Densitometric analyses of the autoradiograms were performed using a bioimaging analyzer and image gauge.
Regional tissue uptake was quantified in terms of %ID/g based on [
125 I]labeled external standards. Regions of interest were manually placed over the LC, hippocampus, thalamus, hypothalamus, striatum, frontal cortex, and anteroventricular thalamic nucleus (AVTN).
In Vitro Autoradiographic Experiments
An in vitro autoradiographic experiment was performed according to the method reported previously. 15 The frozen brains were serially cut into 20 mm thick coronal sections with a cryostat; the sections were mounted on 0.2% gelatin/0.03% chromium potassium sulfate-coated slides and kept at 280uC until use (control group: n 5 5; reserpine-treated group: n 5 5). The sections (two slides per animal, that is, one for total binding and one for nonspecific binding) were preincubated for 15 minutes at 25uC in 50 mM Tris-HCl buffer at pH 7.4 containing 120 mM NaCl and 5 mM KCl. The incubations were carried out with 3.0 nM [ hours. Densitometric analyses of the autoradiograms were performed using a bioimaging analyzer (BAS3000, Fuji Photo Film) and image gauge (Fuji Photo Film). Regions of interest were manually placed over the LC, hippocampus, thalamus, hypothalamus, striatum, frontal cortex, and AVTN.
Optical density values were converted to fmol/mg of protein using a computer-generated regression analysis that compared imaging plate densities produced by tissue sections and radioactive standards. The concentration values were then multiplied by (K D + c)/c to obtain maximum binding (B max ) 16 
Statistical Analysis
Results are expressed as mean 6 SD. For statistical data analysis, one-way analysis of variance with a post hoc Tukey test was applied for multiple comparisons. The unpaired alternate Welch t-test was applied for two group comparisons. A probability value of less than .05 was considered to indicate a significant difference.
Evaluation of (S,S)-IPBM in a Rat Model of Depression
Results
Reserpine Treatment
The changes in body characteristics on day 14 induced by chronic treatment with reserpine are shown in Table 1 . There were significant differences in rectal temperature and body weight between the rats treated with reserpine and the control rats. This is consistent with previous reports that the rectal temperature was decreased in reserpine-treated rats. 
In Vitro Autoradiographic Experiments
To investigate regional NET expression, we performed in vitro autoradiographic experiments using [ 3 H]nisoxetine.
As shown in Figure 3 , in the control group, the binding of [ 3 H]nisoxetine was highest in the LC followed by the AVTN, known as NET-rich regions. 19, 20 There was a good correlation between the regional uptake of (S,S)- 
Discussion
In this study, we demonstrated that radioiodinated (S,S)-IPBM has good potential as a quantitative imaging biomarker of regional NET expression in normal as well as diseased brains. The regional uptake of (S,S)-
in both normal and depression model rat brains correlated closely with the regional NET expression. Although NET is generally considered to be an important target in studies of major depression, there have been a few positron emission tomographic (PET) tracers targeting NET. [21] [22] [23] In clinical studies, (S,S)- 27 Besides the regions that highly express NET, the regions with medium expression of NET (eg, frontal cortex, hippocampus, thalamus, and hypothalamus) are considered to be important because the functions in these regions control the majority of human systems. Furthermore, it may be difficult to analyze regions with high expression of NET (eg, LC and AVTN) by PET and singlephoton emission computed tomography (SPECT) in clinical studies owing to the small sizes of these regions. Therefore, quantification of NET in the cortical regions could be essential for studies of major depression, and radioiodinated (S,S)-IPBM has the possibility to quantify NET in the cortical regions with SPECT because radioiodinated (S,S)-IPBM has a high affinity for and selectivity to NET and metabolites of radioiodinated (S,S)-IPBM do not accumulate in the skull. 1 However, there is the limitation using the reserpine-treated model of concluding that radioiodinated (S,S)-IPBM is useful in the cortical regions because there were no significant differences in the uptake of radioiodinated (S,S)-IPBM in those regions between the control and reserpine-treated model rats. The expression of NET in the cortical regions in our mode was not decreased, but Lee and colleagues reported that the B max value of NET in the cerebral cortex was decreased in reserpine-treated rats, 28 and this contradiction with our data may be due to the dose (0.1 mg/kg in our study versus 0.5 mg/kg in Lee and colleagues study) and the duration of treatment (14 days in our study versus 18 days in Lee and colleagues study). Therefore, if their model had been Furthermore, this is believed to be the first report regarding regional changes in NET expression in the brain Evaluation of (S,S)-IPBM in a Rat Model of Depression after reserpine treatment. The reserpine-treated depression model is one of the most frequently used models of depression. 13, 18, 29, 30 There have been some reports about the expression of NET in the brain of rats after reserpine treatment to date. 28, 31 However, these reports were forcused on a particular region of the brain. Cubells and colleagues reported that the messenger ribonucleic acid of NET was decreased in the LC region of rats treated with reserpine. 31 In addition, Lee and colleagues reported that the B max value of NET in the cerebral cortex was decreased in reserpine-treated rats. 28 Although the B max value of the cerebral cortex in the present study was not significantly decreased, our data on changes in NET expression were largely consistent with previous reports. The reduction in NET expression might be a compensatory mechanism for the depletion of norepinephrine caused by the treatment with reserpine; a similar phenomenon was observed in the brains of depression patients. 5 Therefore, it is important to detect the expression of NET in the brain for elucidating the role of NET in depression. Radioiodinated (S,S)-IPBM could be a useful tool for this purpose.
Conclusion
The reduction in the radioiodinated (S,S)-IPBM uptake in the rat model of depression correlated with that of the NET expression. 
